AR and neoplasm: In cancerous cells, the mitogenic activity of AR is considered a key event for the maintenance of the transformed status and for tumor expansion as well as progression, and for this reason the standard treatment for AR-positive PCas includes androgen deprivation therapy (ADT), which targets the AR signaling pathway (Shen and Balk, 2009).